Skip to Content

Fosamax

In the US, Fosamax (alendronate systemic) is a member of the drug class bisphosphonates and is used to treat Aseptic Necrosis, Osteoporosis, Paget's Disease and Prevention of Osteoporosis.

US matches:

UK matches:

Ingredient matches for Fosamax

Alendronate

Alendronic Acid is reported as an ingredient of Fosamax in the following countries:

  • China
  • Colombia
  • Cyprus
  • Egypt
  • Lebanon
  • Norway
  • Tunisia

Alendronic Acid sodium and Alendronic Acid (a derivative of Alendronic Acid) is reported as an ingredient of Fosamax in the following countries:

  • Denmark

Alendronic Acid sodium monohydrate (a derivative of Alendronic Acid) is reported as an ingredient of Fosamax in the following countries:

  • France
  • Thailand
  • United Kingdom

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Fosamax in the following countries:

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Chile
  • Czech Republic
  • Finland
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • Ireland
  • Italy
  • Lithuania
  • Malta
  • Netherlands
  • New Zealand
  • Norway
  • Peru
  • Poland
  • Portugal
  • Romania
  • Serbia
  • Slovakia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Turkey
  • United Kingdom
  • United States
  • Venezuela

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide